Answers are grounded in this paper and cite their sources.
Senolytic drugs raise the expectation that they can specifically eliminate a subset of senescent cells in a given tissue. In this study, we have exemplarily analyzed if a 3-day treatment of human blood samples in vitro would reduce age-associated biomarkers, with a particular focus on epigenetic age-predictions. Of eight tested compounds, JQ1, RG7112, nutlin-3a, and AMG232 reduced epigenetic age, indicating that this approach may be useful in drug screening for senolytic compounds.
No takes yet. Share an insight, caveat, or question.
Tharmapalan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: